A comprehensive immunohistochemical study has shown that SALL4 is consistently expressed in all germ cell tumors, whereas in non-germ cell tumors, such as serous ovarian cancer, SALL4 expression occurs in approximately 20% of cases, usually in poorly differentiated forms. The gene discussed is SALL4; the disease is ovarian serous adenocarcinoma.